Loading...
XWAR
SCP
Market cap111mUSD
Dec 05, Last price  
147.80PLN
1D
0.96%
1Q
-3.40%
IPO
956.47%
Name

Scope Fluidics SA

Chart & Performance

D1W1MN
XWAR:SCP chart
P/E
6.16
P/S
3,075.51
EPS
24.00
Div Yield, %
—
Shrs. gr., 5y
3.32%
Rev. gr., 5y
195.27%
Revenues
131k
-74.61%
4,506,051183,2321,8000000404,000516,000131,000
Net income
65m
P
-637,47500000-5,065,000318,489,000-18,785,00065,421,000
CFO
-25m
L+31.73%
535,68800000-22,190,000-28,158,000-19,057,000-25,104,000
Dividend
Mar 24, 202385.57 PLN/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Scope Fluidics S.A., a biotechnology company, engages in the designing and developing projects based on microfluidic technologies in medical diagnostics and healthcare. It offers BacterOMIC, an antibiotic susceptibility testing. The company was founded in 2010 and is based in Warsaw, Poland.
URL
https://scopefluidics.com/
IPO date
Aug 16, 2017
Employees
79
Domiciled in
PL
Incorporated in
PL

Valuation

Title
PLN in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT